ANGO AngioDynamics

NASDAQ
$11.52

AngioDynamics (ANGO) is expected to report earnings on January 7, 2027, before the market open. The consensus earnings estimate is a loss of $0.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.9% since its last earnings release on October 8, 2026.

AngioDynamics Beat Expectations, Reaffirms
Thursday, October 8, 2026 · 6:02 AM ET
Earnings Date
2nd Quarter, Nov 2026
Jan 7
Thursday · 6:00 AM ET
Earnings Whisper
-
vs ($0.09)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $11.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AngioDynamics

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.